Skip to main content

SPARC · Sun Pharma Advanced Research Company Limited · Financials

205.80 INR -6.95 (-3.27%) At close · Nov 13
Volume · Nov 13 130.25K Avg daily vol (3M) 101.82K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
18.79B +2518.3%
FY2026 Revenue FY2024–FY2026
Net Income
15.56B +554%
FY2026 Net Income FY2024–FY2026
Operating Cash Flow
-2.39B +33.7%
FY2026 Operating Cash Flow FY2024–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024
INR 19.32B 18.79B 717.7M 755.5M
INR 93.7M 102.1M 123.9M 125.1M
INR 286.7M 341.3M 90.4M 16.9M
INR 16.36B 15.53B -3.43B -3.87B
INR -1.2M -1.9M -2.7M 3.8M
INR 16.36B 15.56B -3.43B -3.87B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.